Why not now? Targeting Plasmodium falciparum histone methyltransferases for next-generation antimalarial strategies
{{output}}
Plasmodium falciparum is the major human malaria parasite and its treatment remains challenging, with current artemisinin-based combination therapies increasingly compromised by emerging resistance in several regions. Although the pre-erythrocytic vaccines, Mo... ...